Jubilant HollisterStier Sterile Expansion Project Continues
Jubilant HollisterStier added an ampul filling line utilizing a rigid barrier system.
Jubilant HollisterStier has completed the first phase of a sterile-manufacturing capacity expansion at the company’s Montreal-based manufacturing facility with the addition of a new ampoule filling line utilizing a rigid barrier system. The new manufacturing area will expand ampoule manufacturing capacity in Montreal by nearly 200%. In addition, expansions to the sterile areas at Jubilant HollisterStier have been optimized through implementation of lean and six-sigma initiatives.
The new area is scheduled to be ready for product on Sept. 9, 2013. A significant portion of the expanded capacity has already been allocated to new customer products that will be manufactured at the site. Jubilant HollisterStier is a subsidiary of Jubilant Life Sciences, an integrated pharmaceutical and life sciences company headquartered in India.
Source: Jubilant HollisterStier
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
